Veru settles $8.8M Onconetix promissory notes for $6.3M cash and preferred stock/warrants

VERU INC.

Outstanding principal under two promissory notes totaled $8,826,155.41 as of September 22, 2025.
Veru accepted a cash payment of $6,326,155.41, 3,125 shares of Series D Convertible Preferred Stock (stated value $1,000/share), and 846,975 warrants.
Settlement Amounts paid on September 24, 2025; Promissory Notes and Forbearance Agreement terminated.
No assurance of future cash proceeds from the preferred stock, warrants, or underlying common shares.
Release of all claims by Veru against Onconetix upon receipt of settlement consideration.

item 1.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.